Business · CNBC Technology
In January, OpenAI launched ChatGPT Health, allowing people to securely connect their medical records and wellness apps to the AI
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
The company said the new health experience was not intended for diagnosis and treatment.
Key facts
- In March, pharmaceutical giant Eli Lilly signed a $2.75 billion deal with Insilico Medicine to bring drugs developed using AI to market
- People should be using AI much more than they do today," according to Alex Zhavoronkov, founder and CEO of AI drug discovery company Insilico Medicine
- CNBC's Ashley Capoot and Annie Palmer contributed to this report
- In January, OpenAI launched ChatGPT Health, allowing people to securely connect their medical records and wellness apps to the AI chatbot
Summary
You may already be familiar with AI taking notes in your doctor's office, or being used to help book appointments or analyze medical images. But some experts believe consumers should be using AI even more to help understand their health. "People should be using AI much more than they do today," according to Alex Zhavoronkov, founder and CEO of AI drug discovery company Insilico Medicine. "Many of those AI models that are used by consumers, they achieve the level of capability that is close to some of the doctors and sometimes better," Zhavoronkov said, speaking on a panel at CNBC's CONVERGE LIVE event in Singapore on Wednesday. He advocated the use of AI to answer basic health questions, such as: "What should the reporter eat?.